LIFECORE BIOMEDICAL, INC. Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent
LIFECORE BIOMEDICAL, INC. (LFCR) reported Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent of $586.00 thousand for the 12-month period ending 2023-05-28, per its 10-K filed 2024-08-26.
Discontinued › Income Statement › Unrealized Gains
us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent · last filed 2024-08-26
- LIFECORE BIOMEDICAL, INC. other comprehensive income (loss), net of tax, portion attributable to parent for the quarter ending 2023-05-28 was $0.00, a 100.00% decline year-over-year.
- LIFECORE BIOMEDICAL, INC. other comprehensive income (loss), net of tax, portion attributable to parent for the quarter ending 2023-02-26 was $0.00, a 100.00% decline year-over-year.
- LIFECORE BIOMEDICAL, INC. other comprehensive income (loss), net of tax, portion attributable to parent for the quarter ending 2022-11-27 was $286.00K, a 62.50% increase year-over-year.
- LIFECORE BIOMEDICAL, INC. other comprehensive income (loss), net of tax, portion attributable to parent for the quarter ending 2022-08-28 was $300.00K, a 18.03% decline year-over-year.
- LIFECORE BIOMEDICAL, INC. other comprehensive income (loss), net of tax, portion attributable to parent for fiscal 2023 was $586.00K, a 24.09% decline from fiscal 2022.
- LIFECORE BIOMEDICAL, INC. other comprehensive income (loss), net of tax, portion attributable to parent for fiscal 2022 was $772.00K, a 46.76% decline from fiscal 2021.
- LIFECORE BIOMEDICAL, INC. other comprehensive income (loss), net of tax, portion attributable to parent for fiscal 2021 was $1.45M.
- LIFECORE BIOMEDICAL, INC. other comprehensive income (loss), net of tax, portion attributable to parent for fiscal 2020 was -$2.87M.
| Period end | Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent 3 month | Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent 6 month | Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent 9 month | Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent 12 month |
|---|---|---|---|---|
| 2023-05-28 | $0.00 derived: 10-K 12 month − 10-K 9 month · filed 2024-08-26 | $0.00 derived: sum of 2 quarters · filed 2024-08-26 | $286.00K derived: sum of 3 quarters · filed 2024-08-26 | $586.00K 10-K · filed 2024-08-26 |
| 2023-02-26 | $0.00 10-Q · filed 2023-06-02 | $286.00K derived: sum of 2 quarters · filed 2024-08-09 | $586.00K 10-K · filed 2024-03-20 | $712.00K derived: sum of 4 quarters · filed 2024-08-26 |
| 2022-11-27 | $286.00K 10-Q · filed 2024-08-09 | $586.00K 10-K · filed 2024-03-20 | $712.00K derived: sum of 3 quarters · filed 2024-08-26 | $816.00K derived: sum of 4 quarters · filed 2024-08-26 |
| 2022-08-28 | $300.00K 10-Q · filed 2024-08-09 | $426.00K derived: sum of 2 quarters · filed 2024-08-26 | $530.00K derived: sum of 3 quarters · filed 2024-08-26 | $706.00K derived: sum of 4 quarters · filed 2024-08-26 |
| 2022-05-29 | $126.00K derived: 10-K 12 month − 10-K 9 month · filed 2024-08-26 | $230.00K derived: sum of 2 quarters · filed 2024-08-26 | $406.00K derived: sum of 3 quarters · filed 2024-08-26 | $772.00K 10-K · filed 2024-08-26 |
| 2022-02-27 | $104.00K 10-K · filed 2024-03-20 | $280.00K derived: sum of 2 quarters · filed 2024-03-20 | $646.00K 10-K · filed 2024-03-20 | $1.00M derived: sum of 4 quarters · filed 2024-03-20 |
| 2021-11-28 | $176.00K 10-K · filed 2024-03-20 | $542.00K 10-K · filed 2024-03-20 | $900.00K derived: sum of 3 quarters · filed 2024-03-20 | $1.29M derived: sum of 4 quarters · filed 2024-03-20 |
| 2021-08-29 | $366.00K 10-K · filed 2024-03-20 | $724.00K derived: sum of 2 quarters · filed 2024-03-20 | $1.11M derived: sum of 3 quarters · filed 2024-03-20 | $1.51M derived: sum of 4 quarters · filed 2024-03-20 |
| 2021-05-30 | $358.00K derived: 10-K 12 month − 10-K 9 month · filed 2024-03-20 | $745.00K derived: sum of 2 quarters · filed 2024-03-20 | $1.15M derived: sum of 3 quarters · filed 2024-03-20 | $1.45M 10-K · filed 2024-03-20 |
| 2021-02-28 | $387.00K 10-K · filed 2024-03-20 | $788.00K derived: sum of 2 quarters · filed 2024-03-20 | $1.09M 10-K · filed 2024-03-20 | -$884.00K derived: sum of 4 quarters · filed 2024-03-20 |
| 2020-11-29 | $401.00K 10-K · filed 2024-03-20 | $705.00K 10-K · filed 2024-03-20 | -$1.27M derived: sum of 3 quarters · filed 2024-03-20 | -$1.68M derived: sum of 4 quarters · filed 2024-03-20 |
| 2020-08-30 | $304.00K 10-K · filed 2024-03-20 | -$1.67M derived: sum of 2 quarters · filed 2024-03-20 | -$2.08M derived: sum of 3 quarters · filed 2024-03-20 | -$1.96M derived: sum of 4 quarters · filed 2024-03-20 |
| 2020-05-31 | -$1.98M derived: 10-K/A 12 month − 10-Q 9 month · filed 2023-03-16 | -$2.39M derived: sum of 2 quarters · filed 2023-03-16 | -$2.26M derived: sum of 3 quarters · filed 2023-03-16 | -$2.87M 10-K/A · filed 2023-03-16 |
| 2020-02-23 | -$411.00K 10-Q · filed 2021-04-08 | -$284.00K derived: sum of 2 quarters · filed 2021-04-08 | -$896.00K 10-Q · filed 2021-04-08 | |
| 2019-11-24 | $127.00K 10-Q · filed 2021-04-08 | -$485.00K 10-Q · filed 2021-01-07 | ||
| 2019-08-25 | -$612.00K 10-Q · filed 2021-04-08 | |||
| 2017-02-26 | $103.00K 10-Q · filed 2017-04-07 | $430.00K derived: sum of 2 quarters · filed 2017-04-07 | $430.00K 10-Q · filed 2017-04-07 | |
| 2016-11-27 | $327.00K 10-Q · filed 2017-01-05 | $327.00K 10-Q · filed 2017-01-05 | ||
| 2015-03-01 | $6.13M 10-Q · filed 2015-04-02 | $11.16M derived: sum of 2 quarters · filed 2015-04-02 | $14.88M 10-Q · filed 2015-04-02 | $22.05M derived: sum of 4 quarters · filed 2015-04-02 |
| 2014-11-30 | $5.03M 10-Q · filed 2015-01-09 | $8.76M 10-Q · filed 2015-01-09 | $15.93M derived: sum of 3 quarters · filed 2015-01-09 | $26.03M derived: sum of 4 quarters · filed 2015-04-02 |
| 2014-08-31 | $3.73M 10-Q · filed 2014-10-08 | $10.90M derived: sum of 2 quarters · filed 2014-10-08 | $21.00M derived: sum of 3 quarters · filed 2015-04-02 | $26.36M derived: sum of 4 quarters · filed 2015-04-02 |
| 2014-05-25 | $7.17M derived: 10-K 12 month − 10-Q 9 month · filed 2014-08-01 | $17.27M derived: sum of 2 quarters · filed 2015-04-02 | $22.64M derived: sum of 3 quarters · filed 2015-04-02 | $29.93M 10-K · filed 2014-08-01 |
| 2014-02-23 | $10.10M 10-Q · filed 2015-04-02 | $15.47M derived: sum of 2 quarters · filed 2015-04-02 | $22.75M 10-Q · filed 2015-04-02 | $28.55M derived: sum of 4 quarters · filed 2015-04-02 |
| 2013-11-24 | $5.37M 10-Q · filed 2015-01-09 | $12.65M 10-Q · filed 2015-01-09 | $18.45M derived: sum of 3 quarters · filed 2015-01-09 | $26.00M derived: sum of 4 quarters · filed 2015-01-09 |
| 2013-08-25 | $7.29M 10-Q · filed 2014-10-08 | $13.09M derived: sum of 2 quarters · filed 2014-10-08 | $20.63M derived: sum of 3 quarters · filed 2014-10-08 | $32.52M derived: sum of 4 quarters · filed 2014-10-08 |
| 2013-05-26 | $5.80M derived: 10-K 12 month − 10-Q 9 month · filed 2014-08-01 | $13.35M derived: sum of 2 quarters · filed 2014-08-01 | $25.24M derived: sum of 3 quarters · filed 2014-08-01 | $32.26M 10-K · filed 2014-08-01 |
| 2013-02-24 | $7.55M 10-Q · filed 2014-03-28 | $19.44M derived: sum of 2 quarters · filed 2014-03-28 | $26.46M 10-Q · filed 2014-03-28 | $46.69M derived: sum of 4 quarters · filed 2014-08-01 |
| 2012-11-25 | $11.89M 10-Q · filed 2014-01-03 | $18.92M 10-Q · filed 2014-01-03 | $39.14M derived: sum of 3 quarters · filed 2014-08-01 | $39.17M derived: sum of 4 quarters · filed 2014-08-01 |
| 2012-08-26 | $7.03M 10-Q · filed 2013-09-26 | $27.25M derived: sum of 2 quarters · filed 2014-08-01 | $27.28M derived: sum of 3 quarters · filed 2014-08-01 | $27.35M derived: sum of 4 quarters · filed 2014-08-01 |
| 2012-05-27 | $20.22M derived: 10-K 12 month − 10-Q 9 month · filed 2014-08-01 | $20.25M derived: sum of 2 quarters · filed 2014-08-01 | $20.32M derived: sum of 3 quarters · filed 2014-08-01 | $20.28M 10-K · filed 2014-08-01 |
| 2012-02-26 | $33.00K 10-Q · filed 2013-04-04 | $99.00K derived: sum of 2 quarters · filed 2013-04-04 | $65.00K 10-Q · filed 2013-04-04 | |
| 2011-11-27 | $66.00K 10-Q · filed 2013-01-04 | $32.00K 10-Q · filed 2013-01-04 | ||
| 2011-08-28 | -$34.00K 10-Q/A · filed 2013-01-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ADC Therapeutics SA (ADCT) | $0.163B | -1.39 | |
| Minerva Neurosciences, Inc. (NERV) | United States | $0.165B | -0.66 |
| Tonix Pharmaceuticals Holding Corp. (TNXP) | United States | $0.166B | -1.34 |
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |
| Organogenesis Holdings Inc. (ORGO) | United States | $0.182B | -3.70 |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B |